Protein Summary
Part of a kinesin motor-adapter complex that is critical for the anterograde axonal transport of active zone components and contributes to activity-dependent presynaptic assembly during neuronal development. Syntabulin/GOLSYN is part of a kinesin motor-adaptor complex that is critical for the anterograde axonal transport of active zone components and contributes to activity-dependent presynaptic assembly during neuronal development (Cai et al., 2007 [PubMed 17611281]).[supplied by OMIM, Mar 2008]
- ENST00000276646
- ENSP00000276646
- ENSG00000147642
- ENST00000399066
- ENSP00000382019
- ENST00000408889
- ENSP00000386196
- ENST00000408908
- ENSP00000386154
- ENST00000422135
- ENSP00000407118
- ENST00000433638
- ENSP00000403544
- ENST00000440310
- ENSP00000404369
- ENST00000446070
- ENSP00000414748
- ENST00000528331
- ENSP00000436041
- ENST00000528647
- ENSP00000432501
- ENST00000532779
- ENSP00000436266
- ENST00000533065
- ENSP00000432962
- ENST00000533171
- ENSP00000434679
- ENST00000533895
- ENSP00000433446
- GOLSYN
- KIAA1472
- OCSYN
- SNPHL
- GOLSYN
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
cellular component | 0.76 | ||
small molecule perturbation | 0.76 | ||
tissue sample | 0.68 | ||
virus perturbation | 0.64 | ||
histone modification site profile | 0.52 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 18.95 (req: < 5)
Gene RIFs: 4 (req: <= 3)
Antibodies: 15 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 18.95 (req: >= 5)
Gene RIFs: 4 (req: > 3)
Antibodies: 15 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 8
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0